These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 19882788

  • 1. Moxifloxacin: new indication. Do not use in gynaecological infections or other conditions.
    Prescrire Int; 2009 Oct; 18(103):207. PubMed ID: 19882788
    [Abstract] [Full Text] [Related]

  • 2. Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections.
    Prescrire Int; 2009 Oct; 18(103):206. PubMed ID: 19882787
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study.
    Judlin P, Liao Q, Liu Z, Reimnitz P, Hampel B, Arvis P.
    BJOG; 2010 Nov; 117(12):1475-84. PubMed ID: 20716255
    [Abstract] [Full Text] [Related]

  • 4. A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.
    Heystek M, Ross JD, PID Study Group.
    Int J STD AIDS; 2009 Oct; 20(10):690-5. PubMed ID: 19815913
    [Abstract] [Full Text] [Related]

  • 5. Intravenous moxifloxacin. Even more harmful than the oral form.
    Prescrire Int; 2011 Jun; 20(117):151. PubMed ID: 21678703
    [No Abstract] [Full Text] [Related]

  • 6. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [Abstract] [Full Text] [Related]

  • 7. Moxifloxacin--a new fluoroquinolone antibacterial.
    Drug Ther Bull; 2004 Aug; 42(8):61-2. PubMed ID: 15310155
    [Abstract] [Full Text] [Related]

  • 8. A comparison of treatment outcomes for moxifloxacin versus ofloxacin/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease.
    Boothby M, Page J, Pryor R, Ross JD.
    Int J STD AIDS; 2010 Mar; 21(3):195-7. PubMed ID: 20215625
    [Abstract] [Full Text] [Related]

  • 9. Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis.
    Chang CM, Lee NY, Lee HC, Lee IW, Wu CJ, Lin YS, Ko WC.
    Ann Pharmacother; 2008 Apr; 42(4):580-3. PubMed ID: 18349304
    [Abstract] [Full Text] [Related]

  • 10. [Moxifloxacin (Kanavig), ophthalmic administration].
    J Pharm Belg; 2012 Jun; (2):41-2. PubMed ID: 22978015
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence-based review of moxifloxacin.
    O'Brien TP.
    Int Ophthalmol Clin; 2006 Jun; 46(4):61-72. PubMed ID: 17060792
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis.
    Belfort R, Gabriel L, Martins Bispo PJ, Muccioli C, Zacharias Serapicos PC, Clark L, Bell B, Bartell J, Stroman DW, Höfling-Lima AL.
    Adv Ther; 2012 May; 29(5):416-26. PubMed ID: 22562783
    [Abstract] [Full Text] [Related]

  • 15. Moxifloxacin and torsade de pointes.
    Dale KM, Lertsburapa K, Kluger J, White CM.
    Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
    [Abstract] [Full Text] [Related]

  • 16. Moxifloxacin for bacterial keratitis.
    Rosenberg J, Eisen L, Kim J.
    Ophthalmology; 2008 Jun; 115(6):1103; author reply 1103. PubMed ID: 18519075
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Penetration and accumulation of moxifloxacin in uterine tissue.
    Stass H, Kubitza D, Aydeniz B, Wallwiener D, Halabi A, Gleiter C.
    Int J Gynaecol Obstet; 2008 Aug; 102(2):132-6. PubMed ID: 18501909
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens.
    Hoeffken G, Talan D, Larsen LS, Peloquin S, Choudhri SH, Haverstock D, Jackson P, Church D.
    Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):772-5. PubMed ID: 15605184
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.